PL3849582T3 - Peptydy i ich zastosowania medyczne - Google Patents
Peptydy i ich zastosowania medyczneInfo
- Publication number
- PL3849582T3 PL3849582T3 PL19784136.4T PL19784136T PL3849582T3 PL 3849582 T3 PL3849582 T3 PL 3849582T3 PL 19784136 T PL19784136 T PL 19784136T PL 3849582 T3 PL3849582 T3 PL 3849582T3
- Authority
- PL
- Poland
- Prior art keywords
- peptides
- medical uses
- medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT201800008493 | 2018-09-11 | ||
| PCT/IB2019/057636 WO2020053772A1 (en) | 2018-09-11 | 2019-09-11 | Peptides and medical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3849582T3 true PL3849582T3 (pl) | 2026-05-11 |
Family
ID=64607074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19784136.4T PL3849582T3 (pl) | 2018-09-11 | 2019-09-11 | Peptydy i ich zastosowania medyczne |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12441765B2 (pl) |
| EP (1) | EP3849582B1 (pl) |
| JP (2) | JP2022500465A (pl) |
| KR (1) | KR20210062649A (pl) |
| CN (1) | CN112996528B (pl) |
| AU (1) | AU2019337806B2 (pl) |
| CA (1) | CA3112169A1 (pl) |
| ES (1) | ES3059260T3 (pl) |
| PL (1) | PL3849582T3 (pl) |
| WO (1) | WO2020053772A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020053773A1 (en) * | 2018-09-11 | 2020-03-19 | Anbition S.R.L. | Peptides and medical uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI962413L (fi) * | 1993-12-15 | 1996-07-24 | Univ Texas | CXC-interkriinimolekyylien peptidi-inhibiittoreita |
| EP0987274A1 (en) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
| DK1297016T3 (da) * | 2000-05-12 | 2006-07-10 | Vlaams Interuniv Inst Biotech | Anvendelse af placentavækstfaktorinhibitorer til behandling af patologisk angiogenese, patologisk arteriogenese, inflammation, tumordannelse og/eller vaskulær lækage |
| JP5548616B2 (ja) * | 2007-08-08 | 2014-07-16 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | Ｖｅｇｆｒ−１／ｎｒｐ−１標的化ペプチド |
| JP6184404B2 (ja) * | 2011-06-22 | 2017-08-23 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | グルカゴン／ｇｌｐ−１レセプターコアゴニスト |
| RU2708375C2 (ru) * | 2015-03-02 | 2019-12-06 | Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс | Пептиды для ингибирования ангиогенеза |
| EP3288961B8 (en) * | 2015-04-27 | 2022-04-27 | MacKay Memorial Hospital | Short synthetic peptide for treating diseases and/or conditions related to angiogenesis |
-
2019
- 2019-09-11 KR KR1020217010661A patent/KR20210062649A/ko active Pending
- 2019-09-11 CA CA3112169A patent/CA3112169A1/en active Pending
- 2019-09-11 PL PL19784136.4T patent/PL3849582T3/pl unknown
- 2019-09-11 EP EP19784136.4A patent/EP3849582B1/en active Active
- 2019-09-11 CN CN201980074348.6A patent/CN112996528B/zh active Active
- 2019-09-11 WO PCT/IB2019/057636 patent/WO2020053772A1/en not_active Ceased
- 2019-09-11 AU AU2019337806A patent/AU2019337806B2/en active Active
- 2019-09-11 ES ES19784136T patent/ES3059260T3/es active Active
- 2019-09-11 US US17/275,023 patent/US12441765B2/en active Active
- 2019-09-11 JP JP2021514627A patent/JP2022500465A/ja active Pending
-
2024
- 2024-08-02 JP JP2024128153A patent/JP7830567B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3849582B1 (en) | 2025-12-31 |
| ES3059260T3 (en) | 2026-03-19 |
| JP2022500465A (ja) | 2022-01-04 |
| US12441765B2 (en) | 2025-10-14 |
| WO2020053772A1 (en) | 2020-03-19 |
| JP7830567B2 (ja) | 2026-03-16 |
| EP3849582C0 (en) | 2025-12-31 |
| US20220064216A1 (en) | 2022-03-03 |
| EP3849582A1 (en) | 2021-07-21 |
| CA3112169A1 (en) | 2020-03-19 |
| AU2019337806B2 (en) | 2025-08-14 |
| JP2024150757A (ja) | 2024-10-23 |
| AU2019337806A1 (en) | 2021-05-13 |
| KR20210062649A (ko) | 2021-05-31 |
| CN112996528A (zh) | 2021-06-18 |
| CN112996528B (zh) | 2025-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT202300299T1 (it) | Nuovi polipeptidi e relativi usi medici | |
| IL276877A (en) | Compstatin analogs and their medical uses | |
| ZA201905851B (en) | Peptides and methods for the treatment of diabetes | |
| SG11202006669RA (en) | Peptides and uses thereof | |
| IL280407A (en) | IL-17A binding peptides and their medical uses | |
| ZA201905372B (en) | Therapeutic and neuroprotective peptides | |
| PT3669791T (pt) | Fórceps médico | |
| GB2600592B (en) | Polypeptide and use thereof | |
| EP3882263A4 (en) | GLUCAGON DERIVED PEPTIDE AND USE THEREOF | |
| IL272050A (en) | Synthetic proteins and their therapeutic uses | |
| GB201819200D0 (en) | Polypeptide and uses thereof | |
| ZA202100092B (en) | Modified cas9 protein and use thereof | |
| EP3706771A4 (en) | BCL9 PEPTIDES AND VARIANTS THEREOF | |
| GB2600270B (en) | Polymer-comrprising medical devices and uses thereof | |
| IL278240A (en) | J and their medical/diagnostic uses | |
| ZA201904386B (en) | S-arrestin peptides and therapeutic uses thereof | |
| SG11202007887VA (en) | Cyclic peptides and uses thereof | |
| EP3735277C0 (en) | MEDICAL MATERIALS AND DEVICES | |
| EP3947418C0 (en) | PEPTIDES AND THEIR USE | |
| SG11202101090RA (en) | Cdca1-derived peptide and vaccine containing same | |
| GB201810635D0 (en) | Peptides and cancer treatment | |
| HUP1700012A2 (en) | Novel proteins and use thereof | |
| IL284666A (en) | New peptides and their uses | |
| HK40016468A (en) | S-arrestin peptides and therapeutic uses thereof | |
| GB201806133D0 (en) | Methods and medical uses |